NEXGEL, Inc. (NASDAQ:NXGL) Short Interest Update

NEXGEL, Inc. (NASDAQ:NXGL) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 113,500 shares, an increase of 167.1% from the November 30th total of 42,500 shares. Based on an average daily trading volume, of 104,600 shares, the short-interest ratio is presently 1.1 days. Approximately 2.2% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. raised its position in NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,848 shares of the company’s stock after purchasing an additional 20,000 shares during the period. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 at the end of the most recent reporting period. 2.21% of the stock is currently owned by hedge funds and other institutional investors.

NEXGEL Price Performance

NASDAQ NXGL traded down $0.09 during mid-day trading on Friday, hitting $4.70. The stock had a trading volume of 97,789 shares, compared to its average volume of 49,506. The company has a 50 day simple moving average of $3.55 and a 200 day simple moving average of $2.90. The company has a market cap of $31.92 million, a price-to-earnings ratio of -8.10 and a beta of 0.76. NEXGEL has a 52-week low of $1.84 and a 52-week high of $5.10. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.